# TASIMELTEON
> **ANDA211601** · Abbreviated New Drug Application (Generic) · Sponsor: TEVA PHARMS USA INC · Approved 2022-12-12
## Drug
- **FDA Application Number:** ANDA211601
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** TASIMELTEON
- **Generic name:** TASIMELTEON
- **Active ingredients:** TASIMELTEON
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** TEVA PHARMS USA INC
- **Manufacturer:** Teva Pharmaceuticals, Inc.
- **First approval:** 2022-12-12
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211601)
---
*MORVS · CC0 1.0*